阿米氟沙星与甲氧苄啶-磺胺甲恶唑治疗急性单纯性尿路感染10天疗程的随机对照试验。阿米氟沙星多中心试验组。
Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group.
作者信息
Boyko E J, Iravani A, Silverman M H, Schelling D J, Wright R A
机构信息
University of Colorado Health Science Center, Denver 80262.
出版信息
Antimicrob Agents Chemother. 1990 Apr;34(4):665-7. doi: 10.1128/AAC.34.4.665.
Abstract
We conducted a randomized controlled trial of orally administered amifloxacin versus trimethoprimsulfamethoxazole (TMP-SMX) as treatments of acute uncomplicated urinary tract infection in women. Amifloxacin at a dosage of 200 mg twice a day appeared as safe and effective as TMP-SMX, but amifloxacin at 400 mg twice a day tended to cause adverse events more frequently than did TMP-SMX.
摘要
我们进行了一项随机对照试验，比较口服阿米氟沙星与甲氧苄啶磺胺甲恶唑（TMP-SMX）治疗女性急性单纯性尿路感染的效果。每日两次服用200毫克的阿米氟沙星与TMP-SMX的安全性和有效性相当，但每日两次服用400毫克的阿米氟沙星比TMP-SMX更易引发不良事件。
相似文献
1
Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group.
Antimicrob Agents Chemother. 1990 Apr;34(4):665-7. doi: 10.1128/AAC.34.4.665.
2
Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
J Am Geriatr Soc. 2001 Dec;49(12):1606-13. doi: 10.1046/j.1532-5415.2001.t01-1-49268.x.
3
A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
Am J Med. 1999 Mar;106(3):292-9. doi: 10.1016/s0002-9343(99)00026-1.
4
Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
J Int Med Res. 1992 Nov;20(6):467-74. doi: 10.1177/030006059202000604.
5
Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.
Antimicrob Agents Chemother. 1991 Sep;35(9):1777-81. doi: 10.1128/AAC.35.9.1777.
6
Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study.
Am J Med. 1992 Apr 6;92(4A):71S-74S. doi: 10.1016/0002-9343(92)90313-z.
7
Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
JAMA. 2000;283(12):1583-90. doi: 10.1001/jama.283.12.1583.
8
Antimicrobial agents for treating uncomplicated urinary tract infection in women.
Cochrane Database Syst Rev. 2010 Oct 6(10):CD007182. doi: 10.1002/14651858.CD007182.pub2.
9
A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Am J Med. 2017 Jul;130(7):842-845. doi: 10.1016/j.amjmed.2017.01.025. Epub 2017 Feb 16.
10
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
Clin Ther. 2002 Dec;24(12):2088-104. doi: 10.1016/s0149-2918(02)80099-6.
引用本文的文献
1
Quinolones for uncomplicated acute cystitis in women.
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD003597. doi: 10.1002/14651858.CD003597.pub2.
2
Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.
Antimicrob Agents Chemother. 1991 Sep;35(9):1777-81. doi: 10.1128/AAC.35.9.1777.
本文引用的文献
1
In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.
Antimicrob Agents Chemother. 1984 Sep;26(3):421-3. doi: 10.1128/AAC.26.3.421.
2
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Antimicrob Agents Chemother. 1984 Mar;25(3):377-9. doi: 10.1128/AAC.25.3.377.
3
Antibiotic susceptibility testing by a standardized single disk method.
Am J Clin Pathol. 1966 Apr;45(4):493-6.
4
Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Diagn Microbiol Infect Dis. 1985 Nov;3(6):469-78. doi: 10.1016/s0732-8893(85)80003-1.
5
The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidis.
Drugs Exp Clin Res. 1985;11(7):427-9.
6
Confidence intervals for reporting results of clinical trials.
Ann Intern Med. 1986 Sep;105(3):429-35. doi: 10.7326/0003-4819-105-3-429.
7
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
J Antimicrob Chemother. 1986 May;17(5):623-8. doi: 10.1093/jac/17.5.623.
Zotero 插件